 | Up a level |
Schaffer, Thomas; Schoepfer, Alain M; Seibold, Frank Werner; Juillerat, Pascal; Swiss Inflammatory Bowel Diseases Cohort Study Group, The (2014). Serum ficolin-2 correlates worse than fecal calprotectin and CRP with endoscopic Crohn's disease activity. Journal of Crohn's & Colitis, 8(9), pp. 1125-1132. Oxford University Press 10.1016/j.crohns.2014.02.014
Schoepfer, Alain M; Flogerzi, Beatrice; Fallegger, Silvia; Schaffer, Thomas; Mueller, Stefan; Nicod, Laurent; Seibold, Frank (2008). Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease. American journal of gastroenterology, 103(11), pp. 2799-806. New York, N.Y.: Nature 10.1111/j.1572-0241.2008.02050.x
Müller, Stefan; Schaffer, Thomas; Schoepfer, Alain M; Hilty, Annamarie; Bodmer, Thomas; Seibold, Frank (2008). Partial overlap of anti-mycobacterial, and anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease. World journal of gastroenterology, 14(23), pp. 3650-61. Beijing (China): WJG Press 10.3748/wjg.14.3650
Schoepfer, A M; Schaffer, T; Seibold-Schmid, B; Müller, S; Seibold, F (2008). Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterology and motility, 20(10), pp. 1110-8. Oxford: Blackwell Science 10.1111/j.1365-2982.2008.01166.x
Schaffer, T; Mueller, S; Flogerzi, B; Seibold-Schmid, B; Schoepfer, A; Seibold, F (2007). Anti-Saccharomyces cerevisiae antibodies in Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans. Inflammatory bowel diseases, 13(11), pp. 1339-1346. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20228
Schaffer, T; Mueller, S; Schoepfer, AM; Hilty, A; Bodmer, T; Seibold, F (2007). Association of anti-mycobacterial IgG with antibodies against the yeast Saccharomyces cerevisiae in patients with Crohns's disease. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl 38), 8S. Basel: EMH Editores Medicorum Helveticorum
Schoepfer, AM; Flogerzi, B; Fallegger, S; Schaffer, T; Mueller, S; Nicod, L; Seibold, F (2007). Use of Interferon-gamma Release Assay for the Diagnosis of Latent Infection with Mycobacterium Tuberculosis in Inflammatory Bowel Disease. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl. 38), 5S. Basel: EMH Editores Medicorum Helveticorum
Schoepfer, AM; Schaffer, T; Seibold-Schmid, B; Mueller, S; Seibold, F (2007). Elevated antibodies against Flagellin support the concept of low-grade Mucosal Inflammation in Irritable Bowel Syndrome. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl. 38), 4S. Basel: EMH Editores Medicorum Helveticorum
Schoepfer, AM; Schaffer, T; Seibold-Schmid, B; Mueller, S; Seibold, F (2007). Elevated Antibodies against Flagellin support the Concept of Low Grade Mucosal Inflammation in Irritable Bowel Syndrome. Gastroenterology Philadelphia, Pa.: Elsevier
Schoepfer, AM; Mueller, S; Criblez, D; Schaffer, T; Seibold, F (2007). Circulating Levels of Leptin, Adiponectin and Alpha-MSH in Crohn's Disease Patients differ from a Matched Population. Journal of Crohn's & Colitis(1), AO03. Amsterdam: Elsevier
Mueller, S; Flogerzi, B; Schaffer, T; Fleetwood, A; Schoepfer, A; Seibold, F (2006). Non T-cell derived Galectin-3 is immunoregulatory and is reduced in the inflamed intestinal epithelium in IBD. Gastroenterology, 130/(Suppl 33), A3616/A37. Philadelphia, Pa.: Elsevier
Schaffer, T; Müller, S; Seibold, F (2006). Mechanisms of anti-Saccharomyces cerevisiae antibody development in Crohn's Disease. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 6:(Suppl 33) Basel: EMH Editores Medicorum Helveticorum
Schoepfer, AM; Schaffer, T; Seibold-Schmid, B; Mueller, S; Seibold, F (2006). Antibodies to Flagellin: Clinical significance in Inflammatory bowel disease. American journal of gastroenterology(1101), A1158. New York, N.Y.: Nature
